Financials
- Market Capitalization 234.56 M
- Employee 106
- Founded 2019
- CEO N/A
- Website www.artivabio.com
- Headquarter Delaware, United States
- FIGI BBG00VPZJ0F9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.81
Relación precio/flujo de caja
262.27
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3462 | SRZN Surrozen, Inc. - Common Stock | 21.98 USD | +0.46% | -3.34% | -5.22% | +164.18% | 255.20 M USD | ||
| 3479 | RNAC Cartesian Therapeutics, Inc. - Common Stock | 8.48 USD | -1.62% | -14.69% | -1.62% | -7.42% | 249.16 M USD | ||
| 3499 | ACIU AC Immune SA - Common Stock | 2.39 USD | -0.83% | -3.24% | +0.84% | +16.59% | 243.16 M USD | ||
| 3517 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.58 USD | -0.28% | -1.38% | +1.42% | -54.57% | 238.55 M USD |